Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment (CDH)

Federal University of Uberlandia

Status: Completed

Conditions: Dentine Hypersensitivity; Dentin Sensitivity; Hypersensitivity Dentin; Dentin Hypersensitivity

Treatments: Procedure: Low level laser therapy; Drug: Potassium Nitrate 2%; Drug: Resin modified glass ionomer

Study type: Interventional

Funder types: Other

Identifiers

NCT02931734

CAAE:35634614.2.0000.5152

Details and patient eligibility

About

The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity by the agents Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Full description

Cervical dentin hypersensitivity is a painful condition and is a clinical challenge due to different treatment strategies available. The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity. A hundred forty teeth of healthy patients of both sexes were selected. Visual Analog Scale was used pain (VAS) to measure the intensity of the patient's pain. The teeth will be randomly divided into 7 different groups according to the desensitization treatment under study: Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Enrollment: 140 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• presence of dentin exposure lesions with clinical diagnosis of moderate or severe tooth sensitivity
• good oral hygiene.

Exclusion criteria

• cavities,
• presence of periodontal disease and or parafunctional habits,
• cracks or enamel fractures,
• extensive or unsatisfactory restorations,
• recent restorations involving the labial surface,
• dentures,
• orthodontics.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

140 participants in 7 patient groups

Resin modified glass ionomer (RMGI)

Active Comparator group

Description:

Resin modified glass ionomer; an application every 48 hours; 4 sessions.

Treatment:

Drug: Resin modified glass ionomer

Potassium Nitrate 2% (KF)

Active Comparator group

Description:

Potassium Nitrate and Sodium fluoride 2%; an application every 48 hours; 4 sessions.

Treatment:

Drug: Potassium Nitrate 2%

Low level laser therapy - GaAlAs (LLLT)

Active Comparator group

Description:

Low level laser therapy - GaAlAs; an application every 48 hours; 4 sessions.

Treatment:

Procedure: Low level laser therapy

RMGI and KF

Active Comparator group

Description:

Resin modified glass ionomer and potassium nitrate and sodium fluoride 2%; an application of the two associated products, every 48 hours; 4 sessions.

Treatment:

Drug: Potassium Nitrate 2%

Drug: Resin modified glass ionomer

RMGI and LLLT

Active Comparator group

Description:

Resin modified glass ionomer and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.

Treatment:

Drug: Resin modified glass ionomer

Procedure: Low level laser therapy

KF and LLLT

Active Comparator group

Description:

Potassium Nitrate and Sodium fluoride 2% and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.

Treatment:

Drug: Potassium Nitrate 2%

Procedure: Low level laser therapy

RMGI, KF, LLLT

Active Comparator group

Description:

Resin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.

Treatment:

Drug: Potassium Nitrate 2%

Drug: Resin modified glass ionomer

Procedure: Low level laser therapy